Showing results (141-150 of 227) with videos related to

Sort By:
Pageof 23
Targeted Oncology|June 14, 2022
Serial Tumor Molecular Profiling of Newly Diagnosed HER2-Negative Breast Cancers During Chemotherapy in Combination with Angiogenesis InhibitorsJoan R E Choo, Yi-Hua Jan, Samuel G W Ow, et al.
Plos One|March 31, 2022
BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programmeJenny Liu, Peh Joo Ho, Tricia Hui Ling Tan, et al.
Nature Genetics|July 21, 2014
Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenomaWeng Khong Lim, Choon Kiat Ong, Jing Tan, et al.
British Journal of Cancer|July 17, 2025
Adapting the BOADICEA breast and ovarian cancer risk models for the ethnically diverse UK populationLorenzo Ficorella, Xin Yang, Nasim Mavaddat, et al.
Oncotarget|September 1, 2016
Phase Ib/II randomized, open-label study of doxorubicin and cyclophosphamide with or without low-dose, short-course sunitinib in the pre-operative treatment of breast cancerAndrea L A Wong, Raghav Sundar, Ting-Ting Wang, et al.
European Journal of Epidemiology|February 10, 2019
The association between weight at birth and breast cancer risk revisited using Mendelian randomisationSiddhartha P Kar, Irene L Andrulis, Hermann Brenner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Significant Effect of Polymorphisms in <i>CYP2D6</i> on Response to Tamoxifen Therapy for Breast Cancer: A Prospective Multicenter StudyHitoshi Zembutsu, Seigo Nakamura, Sadako Akashi-Tanaka, et al.
Scientific Reports|October 10, 2025
Profile of the BREATHE cohort for risk-based breast screening in SingaporePeh Joo Ho, Jenny Liu, Su-Ann Goh, et al.
NPJ Breast Cancer|September 30, 2025
Polygenic risk score for breast cancer risk prediction in Asian BRCA1 and BRCA2 pathogenic variants carriersMei-Chee Tai, Joe Dennis, Sue K Park, et al.
Plos One|August 31, 2018
A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter studyHiroshi Onishi, Chihiro Udagawa, Michiaki Kubo, et al.
Pageof 23